Liposomes: Biomedical Applications
- PMID: 33537216
- PMCID: PMC7840352
- DOI: 10.4068/cmj.2021.57.1.27
Liposomes: Biomedical Applications
Abstract
Liposomes, with their flexible physicochemical and biophysical properties, continue to be studied as an important potential a critical drug delivery system. Liposomes have overcome the challenges of conventional free drug therapy by encapsulating therapeutic agents, thereby improving in vivo biodistribution and reducing systemic toxicity. New imaging modalities and interpretation techniques, as well as new techniques for targetable system formulation technique, and tumor environmental information, have affected the search for a means of overcoming the difficulties of conventional liposome formulation. In this review, we briefly discuss how liposomal formulation has been applied across the biomedical field, particularly as a therapy, and the role it may play in the future, when paired with new developments in diagnosis and theranostics. The biological challenges that still remain and the translational obstacles are discussed.
Keywords: Drug Delivery Systems; Liposomes; Neoplasms; Precision Medicine.
© Chonnam Medical Journal, 2021.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT: None declared.
Figures
Similar articles
-
Advances and Challenges of Liposome Assisted Drug Delivery.Front Pharmacol. 2015 Dec 1;6:286. doi: 10.3389/fphar.2015.00286. eCollection 2015. Front Pharmacol. 2015. PMID: 26648870 Free PMC article. Review.
-
Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.Curr Drug Metab. 2022;23(9):678-692. doi: 10.2174/1389200223666220609141459. Curr Drug Metab. 2022. PMID: 35692131 Review.
-
Design of liposomes as drug delivery system for therapeutic applications.Int J Pharm. 2021 May 15;601:120571. doi: 10.1016/j.ijpharm.2021.120571. Epub 2021 Apr 2. Int J Pharm. 2021. PMID: 33812967 Review.
-
Engineered Liposomes in Interventional Theranostics of Solid Tumors.ACS Biomater Sci Eng. 2023 Aug 14;9(8):4527-4557. doi: 10.1021/acsbiomaterials.3c00510. Epub 2023 Jul 14. ACS Biomater Sci Eng. 2023. PMID: 37450683 Review.
-
Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer.Eur J Pharm Sci. 2021 Jan 1;156:105576. doi: 10.1016/j.ejps.2020.105576. Epub 2020 Sep 25. Eur J Pharm Sci. 2021. PMID: 32987115
Cited by
-
Immune Implications of Cholesterol-Containing Lipid Nanoparticles.ACS Nano. 2024 Oct 22;18(42):28480-28501. doi: 10.1021/acsnano.4c06369. Epub 2024 Oct 10. ACS Nano. 2024. PMID: 39388645 Review.
-
Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2.Immunol Res. 2024 Feb;72(1):14-33. doi: 10.1007/s12026-023-09416-x. Epub 2023 Sep 8. Immunol Res. 2024. PMID: 37682455 Review.
-
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy.Mil Med Res. 2023 Apr 28;10(1):20. doi: 10.1186/s40779-023-00455-x. Mil Med Res. 2023. PMID: 37106400 Free PMC article. Review.
-
Advanced Formulation Approaches for Proteins.Handb Exp Pharmacol. 2024;284:69-91. doi: 10.1007/164_2023_647. Handb Exp Pharmacol. 2024. PMID: 37059912 Review.
-
Encapsulated Peptides and Proteins with an Effect on Satiety.Nanomaterials (Basel). 2023 Mar 24;13(7):1166. doi: 10.3390/nano13071166. Nanomaterials (Basel). 2023. PMID: 37049259 Free PMC article. Review.
References
-
- Yuba E. Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications. J Mater Chem B. 2020;8:1093–1107. - PubMed
-
- Beltrán-Gracia E, López-Camacho A, Higuera-Ciapara I, VelázquezFernández JB, Vallejo-Cardona AA. Nanomedicine review: clinical developments in liposomal applications. Cancer Nanotechnol. 2019;10:11
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources